In 2024, 207 varieties passed/are deemed to have passed the consistency evaluation in October, involving 203 companies (counted as group companies), of which 47 companies passed multiple varieties, and Zhengda Tianqing Pharmaceutical Group Co., Ltd. had the largest number of varieties passed.
Chiatai Tianqing ranked first in the "number of varieties passed by the company"

1. Overall situation

In October, a total of 207 varieties passed/are deemed to have passed the consistency evaluation: 151 varieties were deemed to have passed the consistency evaluation when they were launched as newly registered classified generic drugs; 59 varieties passed the evaluation with supplementary applications for generic drug consistency evaluation, an increase of 20 varieties compared to September.

According to the statistics of the approval documents for marketed drugs, 12 varieties were launched in October as newly registered classified generic drugs, and the first was deemed to have passed the consistency evaluation, and 3 varieties passed the evaluation with supplementary applications for consistency evaluation (see Table 2 at the end of the article for details). The first varieties to pass the evaluation are all drugs not included in the centralized procurement.
2. Number of products that have passed the evaluation of enterprises

In terms of the number of products that have passed the evaluation of enterprises, a total of 207 products passed/are deemed to have passed the consistency evaluation in October, involving 203 group companies, of which 47 companies have passed multiple products.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. has the largest number of products that have passed the evaluation, with a total of 6 products; followed by Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd. and Shijiazhuang No. 4 Pharmaceutical Co., Ltd., each with 4 products that have passed/are deemed to have passed the consistency evaluation.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. currently has a total of 126 varieties that have passed/are deemed to have passed the consistency evaluation, of which 44 varieties have passed the evaluation with the supplementary application for consistency evaluation, and 82 varieties have been launched as newly registered generic drugs and are deemed to have passed the consistency evaluation. In October, the 6 varieties that passed the evaluation of Chia Tai Tianqing Pharmaceutical Group Co., Ltd. were all deemed to have passed the consistency evaluation as newly registered generic drugs. The varieties that passed the evaluation were: Letermovir Injection, Indocyanine Green for Injection, Budesonide Nebulized Inhalation Suspension, Posaconazole Injection, Urapidil Hydrochloride Injection, and Emtricitabine Alafenamide Tenofovir Tablets (II).

Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. currently has a total of 35 varieties that have passed/are deemed to have passed the consistency evaluation, of which 29 varieties have passed the evaluation with the supplementary application for consistency evaluation, and 6 varieties have been launched as newly registered generic drugs and are deemed to have passed the consistency evaluation. In October, Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. had a total of 5 products that passed the supplementary application for generic drug consistency evaluation. The approved products are: cefaclor dry suspension, cefixime dispersible tablets, oxytocin injection, cefuroxime sodium for injection, and cefuroxime sodium for injection .

https://news.yaozh.com/archive/44535.html